Brief: Celldex Therapeutics Inc Plans To Continue To Develop Barzolvolimab For PN
22/03/2023 10:13
March 22 (Reuters) - Celldex Therapeutics Inc CLDX.O :
* CELLDEX THERAPEUTICS INC - PLANS TO CONTINUE TO DEVELOP
BARZOLVOLIMAB FOR PN
Source: [ID: https://bit.ly/3TBtHrr]
Further company coverage: CLDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials